Hallucinogen use, unspecified, uncomplicated
ICD-10 F16.90 is a billable code used to indicate a diagnosis of hallucinogen use, unspecified, uncomplicated.
F16.90 refers to the use of hallucinogens, which are substances that alter perception, mood, and various cognitive processes. This code is used when a patient is experiencing hallucinogen use without any specified complications or associated disorders. Hallucinogens can include substances such as LSD, psilocybin (magic mushrooms), and mescaline. The uncomplicated nature of this code indicates that the patient does not exhibit withdrawal symptoms, intoxication effects, or any co-occurring mental health disorders. Clinically, patients may present with altered sensory perceptions, visual or auditory hallucinations, and changes in thought processes. Treatment typically involves supportive care, counseling, and education about substance use. It is crucial for healthcare providers to document the patient's substance use history, including frequency and quantity, to ensure accurate coding and appropriate treatment planning.
Detailed substance use history, including types of hallucinogens used, frequency, and duration.
Patients presenting for evaluation of substance use, seeking treatment for addiction, or experiencing psychological effects from hallucinogen use.
Consideration of co-occurring mental health disorders and the need for a comprehensive treatment plan.
Thorough mental health assessment, including any psychological effects of hallucinogen use.
Patients with altered mental status or those seeking help for psychological distress related to hallucinogen use.
Assessment for any underlying psychiatric conditions that may complicate treatment.
Used when assessing a patient for hallucinogen use.
Comprehensive assessment of substance use history and current symptoms.
Addiction specialists should ensure thorough documentation to support the diagnosis.
F16.90 indicates hallucinogen use that is unspecified and uncomplicated, meaning the patient does not exhibit withdrawal or intoxication symptoms.
Use F16.90 when a patient presents with hallucinogen use without any complications or associated disorders.
Documentation should include the patient's substance use history, frequency of use, and any current symptoms to support the diagnosis.
